|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
91,540,000 |
Market
Cap: |
34.79(M) |
Last
Volume: |
1,296,467 |
Avg
Vol: |
1,292,882 |
52
Week Range: |
$0.38 - $0.9341 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Curis is a biotechnology company focused on the development of therapeutics for the treatment of cancer. Co.'s clinical stage drug candidates are: Emavusertib, which is being tested in a Phase 1/2 dose escalating clinical trial in patients with non-Hodgkin lymphomas; CI-8993, which is a monoclonal antibody; Fimepinostat, which is a small molecule that potently inhibits the activity of histone deacetylase, and phosphotidyl-inositol 3 kinase; CA-170, for which Co. has announced initial data from a clinical study in patients with mesothelioma in conjunction with the Society of lmmunotherapy of Cancer; and CA-327, which is a small molecule antagonist of PDL1 and TIM3.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Noel Mark |
Vice President, Tech. Mgt. |
|
2004-04-28 |
4 |
S |
$5.00 |
$20,000 |
D/D |
(4,000) |
9,375 |
|
- |
|
Noel Mark |
Vice President, Tech. Mgt. |
|
2004-04-28 |
4 |
OE |
$0.84 |
$3,360 |
D/D |
4,000 |
0 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-04-01 |
4 |
S |
$5.03 |
$50,954 |
D/D |
(10,000) |
9,814 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-04-01 |
4 |
OE |
$1.50 |
$15,000 |
D/D |
10,000 |
0 |
|
- |
|
Passeri Daniel R |
President and CEO |
|
2004-04-01 |
4 |
S |
$5.01 |
$76,161 |
D/D |
(15,000) |
18,900 |
|
- |
|
Passeri Daniel R |
President and CEO |
|
2004-04-01 |
4 |
OE |
$1.50 |
$22,500 |
D/D |
15,000 |
0 |
|
- |
|
Noel Mark |
Vice President, Tech. Mgmt. |
|
2004-03-29 |
4 |
S |
$5.00 |
$17,076 |
D/D |
(3,400) |
9,375 |
|
- |
|
Noel Mark |
Vice President, Tech. Mgmt. |
|
2004-03-29 |
4 |
OE |
$0.84 |
$2,856 |
D/D |
3,400 |
0 |
|
- |
|
Noel Mark |
Vice President, Tech. Mgmt. |
|
2004-03-26 |
4 |
S |
$5.00 |
$3,002 |
D/D |
(600) |
0 |
|
- |
|
Noel Mark |
Vice President, Tech. Mgmt. |
|
2004-03-26 |
4 |
OE |
$0.84 |
$504 |
D/D |
600 |
0 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-03-01 |
4 |
S |
$5.06 |
$51,163 |
D/D |
(10,000) |
9,814 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-03-01 |
4 |
OE |
$1.50 |
$15,000 |
D/D |
10,000 |
0 |
|
- |
|
Passeri Daniel R |
President and CEO |
|
2004-03-01 |
4 |
S |
$5.09 |
$76,813 |
D/D |
(15,000) |
18,900 |
|
- |
|
Passeri Daniel R |
President and CEO |
|
2004-03-01 |
4 |
OE |
$1.50 |
$22,500 |
D/D |
15,000 |
0 |
|
- |
|
Noel Mark |
Vice President, Tech. Manage. |
|
2004-02-26 |
4 |
S |
$5.00 |
$20,031 |
D/D |
(4,000) |
9,375 |
|
- |
|
Noel Mark |
Vice President, Tech. Manage. |
|
2004-02-26 |
4 |
OE |
$0.84 |
$3,360 |
D/D |
4,000 |
0 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-02-04 |
4 |
S |
$5.60 |
$1,680 |
D/D |
(300) |
0 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-02-02 |
4 |
S |
$5.61 |
$54,828 |
D/D |
(9,700) |
0 |
|
- |
|
Rubin Lee L |
Senior Vice President Research |
|
2004-02-02 |
4 |
OE |
$1.50 |
$15,000 |
D/D |
10,000 |
0 |
|
- |
|
Noel Mark |
Vice President, Tech. Manage. |
|
2004-02-02 |
4 |
S |
$5.61 |
$22,512 |
D/D |
(4,000) |
9,375 |
|
- |
|
Noel Mark |
Vice President, Tech. Manage. |
|
2004-02-02 |
4 |
OE |
$0.84 |
$3,360 |
D/D |
4,000 |
0 |
|
- |
|
Passeri Daniel R |
President and CEO |
|
2004-02-02 |
4 |
S |
$5.58 |
$84,860 |
D/D |
(15,000) |
18,900 |
|
- |
|
Passeri Daniel R |
President and CEO |
|
2004-02-02 |
4 |
OE |
$1.09 |
$16,350 |
D/D |
15,000 |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-01-20 |
4 |
S |
$6.29 |
$20,362 |
D/D |
(3,150) |
0 |
|
- |
|
Potthoff Mary Elizabeth |
Vice President,General Counsel |
|
2004-01-20 |
4 |
OE |
$0.84 |
$2,646 |
D/D |
3,150 |
0 |
|
- |
|
303 Records found
|
|
Page 10 of 13 |
|
|